Pilot study of H₂ therapy in Parkinson's disease: a randomized double-blind placebo-controlled trial.

A, Yoritaka; M, Takanashi; M, Hirayama; T, Nakahara; S, Ohta; N, Hattori

doi:10.1002/mds.25375

Public

Pilot study of H₂ therapy in Parkinson's disease: a randomized double-blind placebo-controlled trial.

Shared by NobleBlocks on Feb 11, 2013 • 12:00 AM UTC

Authors:

Yoritaka A

Takanashi M

Hirayama M

Abstract

<h4>Background</h4>Oxidative stress is involved in the progression of Parkinson's disease (PD). Recent studies have confirmed that molecular hydrogen (H₂) functions as a highly effective antioxidant in cultured cells and animal models. Drinking H₂-dissolved water (H₂-water) reduced oxidative stress ...

Discussions